Clinical trial for COVID-19
Official title Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants
ClinicalTrials.gov ID: NCT05858502
What this study is testing
What is Blood sample collection?
Investigational blood sample collection being studied for COVID-19
Plain-language explanation of the investigational treatment. It is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is testing whether measuring mucus immunity can help diagnose COVID‑19 and guide better treatments.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65. Healthy volunteers may be eligible.
You may be able to join if
- Aged between 18 and 65 years included
- Whose weight is greater than or equal to 50 kg and whose state of health is compatible with the collection of 55 ml of blood at one time and 111 ml...
- Residing in the Ile-de-France region and able to travel to the 15th arrondissement of Paris for visits to ICAReB-Clin
- Having given their consent to participate in the study
- Benefiting from a Social Security scheme except for the Aide Médicale d'Etat
You likely can't join if
- Subject under a protective measure (e.g., guardianship)
- Participant in another biomedical research
- For women: pregnant or breastfeeding women (declarative)
- Subject with another acute infectious disease
- SARS-CoV-2 RT-PCR result older than 3 days
- Existence of at least 3 co-morbidities known to be factors of severity (and therefore representing risks of hospitalisation during follow-up)
See the full eligibility criteria
- Aged between 18 and 65 years included
- Whose weight is greater than or equal to 50 kg and whose state of health is compatible with the collection of 55 ml of blood at one time and 111 ml in 28 days
- Residing in the Ile-de-France region and able to travel to the 15th arrondissement of Paris for visits to ICAReB-Clin
- Having given their consent to participate in the study
- Benefiting from a Social Security scheme except for the Aide Médicale d'Etat
- Subject tested positive for SARS-CoV-2 by RT-PCR in one of the participating laboratories for less than 72 hours
- Asymptomatic or with symptoms not requiring hospitalization regardless of previous vaccination or infection status for SARS-CoV-2.
- Having tested negative for SARS-CoV-2 by RT-PCR
- Subject with no more than 3 co-morbidities listed by the HAS.
- Subject under a protective measure (e.g., guardianship)
- Participant in another biomedical research
- For women: pregnant or breastfeeding women (declarative)
- Subject with another acute infectious disease
- SARS-CoV-2 RT-PCR result older than 3 days
- Existence of at least 3 co-morbidities known to be factors of severity (and therefore representing risks of hospitalisation during follow-up)
- Existence of a previous known SARS-CoV-2 positivity less than 1 month old (whatever the method used: RT-PCR or antigenic test)
- SARS-CoV-2 infected participant group criteria: \- For symptomatic people: onset of symptoms more than 4 days ago
- Known history of infection and/or COVID-19 vaccination, within the previous 3 months
The study team makes the final eligibility decision.
Where it is enrolling
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Paris, France. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.